Stephen Simpson
Stephen Simpson
Stop FollowingStephen Simpson
View as an RSS Feed
View Stephen Simpson's Articles BY TICKER:
A,
ABB,
ABT,
ACHN,
ACI,
ADI,
ADTN,
AEP,
AES,
AET,
AEZS,
AGCO,
AIMC,
ALGN,
ALKS,
ALNY,
ALPMY.PK,
ALU,
ALXN,
AME,
AMED,
AMGN,
AMRN,
AMX,
ANFI,
ANGO,
APNHY.PK,
ARAY,
ARCO,
ARIA,
ARQL,
ASOMY.PK,
ATHN,
ATLKY.PK,
ATRC,
AUXL,
AVGO,
AZN,
BA,
BAC,
BAX,
BBT,
BCR,
BDX,
BIIB,
BIOD,
BMRN,
BMTI,
BMY,
BP,
BRCD,
BRFS,
BRK.B,
BSFT,
BSX,
BTU,
C,
CAT,
CBD,
CBST,
CELG,
CFN,
CFX,
CHKP,
CLDX,
CMA,
CMI,
CNH,
COO,
COP,
COV,
CPHD,
CR,
CSCO,
CSII,
CVGI,
CVV,
CVX,
CYCC,
DD,
DE,
DHR,
DIS,
DNDN,
DUSA,
EAC,
ELGX,
ELN,
EMR,
ENDP,
ET,
ETN,
ETRM,
EVAC,
EW,
EXAS,
EXEL,
FAST,
FCFS,
FCX,
FET,
FF,
FFIV,
FHN,
FIRE,
FMX,
FOLD,
FRCOY.PK,
FRX,
FSII,
FUL,
GBX,
GE,
GILD,
GLEKY.PK,
GLPW,
GLW,
GMAN,
GMED,
GNRC,
GPRO,
GRC,
GSK,
GTLS,
GTOMY.PK,
GTXI,
HAL,
HLF,
HLUYY.PK,
HNZ,
HOCPY.PK,
HOGS,
HOLI,
HOLX,
HON,
HRC,
HRL,
HSP,
HTWR,
HURC,
HW,
HYPMY.PK,
IART,
ICUI,
IDIX,
IIVI,
ILMN,
IMGN,
INGIY.PK,
IR,
ISRG,
ISTA,
ITW,
JCI,
JNJ,
JOY,
JPM,
K,
KDN,
KMTUY.PK,
KOP,
KRFT,
LABL,
LAWS,
LECO,
LHCG,
LIFE,
LLY,
LMNX,
LNCR,
LPDX,
LSI,
LXRX,
MAKO,
MASI,
MCD,
MDCI,
MDLZ,
MDT,
MEAS,
MMM,
MNTX,
MON,
MR,
MRK,
MSCC,
MSFT,
MSM,
MTB,
MTL,
MTNOY.PK,
MTRX,
MTW,
MYL,
NAV,
NBHGY.PK,
NBIX,
NKTR,
NOK,
NPO,
NPSP,
NUACF.PK,
NUVA,
NVO,
NVS,
ODFL,
OMER,
OSK,
OZRK,
PAA,
PAY,
PB,
PCXCQ.OB,
PEP,
PFE,
PG,
PH,
PLL,
PMTI,
PNC,
POT,
PRAA,
PRIM,
PRX,
PVD,
PWAV,
QCOR,
QSFT,
RAVN,
RDWR,
RHHBY.OB,
RIG,
RIGL,
SANW,
SASR,
SBMRY.PK,
SCGLY.PK,
SGEN,
SHPG,
SHS,
SI,
SKH,
SLXP,
SNCR,
SNHY,
SNMX,
SNV,
SNY,
SPLK,
SPNC,
SPW,
SSH,
STB,
STJ,
STLD,
SUMR,
SWI,
SWK,
SYK,
TC,
TEAR,
TEN,
TEVA,
TEX,
TKC,
TNGO,
TRCR,
TRGT,
TRUMY.PK,
TSRX,
TWGP,
TWI,
TYPE,
UNH,
UPI,
USB,
UTEK,
UTX,
V,
VICL,
VMW,
VOLC,
VVUS,
WFT,
WLP,
X,
XLNX,
XNPT,
XOM,
XPO,
XRAY,
XYL,
YMI,
ZION,
ZIOP,
ZMH,
ZOLL
-
Incredible Growth Makes ASOS A Must-Watch Name
-
Investors Seem To Be Expecting Too Much From H.B. Fuller
-
Colfax - Balancing Growing Pains And Growth Potential
-
Sauer-Danfoss Should Be Past The Worst
-
VeriFone Now A Falling Knife
-
Living In The Fast (Retailing) Lane Comes At A Price
- Aches And Pains Shouldn't Obscure Achillion's Potential
-
Fortune Could Favor A Bolder Terumo
- A New Paper In JAMA Unlikely To Jam Up Intuitive Surgical
-
Crane Needs To Reach For Better Performance
-
Analog Devices Already Pricing In A Recovery
-
Astellas Needs To Pick A Model To Prosper
-
Risky Sunshine Heart Looks Very Interesting
-
Are Investors Too Thirsty For Growth From Xylem?
-
Growth Needs Resuscitation, But Medtronic Still Looks Like A Value
-
If Investors Won't Buy Shire, Big Pharma Should
-
Investors Are Already Pricing In Lincoln Electric's Recovery
-
Kraft's Cheese Has Already Been Moved Far Enough
-
Skepticism About ABB Means There's Still Time To Buy
-
If Agilent Weakens Further, Take Advantage Of It
-
Mondelez's Sugary Valuation Could Cause Wealth Decay
- PepsiCo Looks Like A Relative Value In Its Sector
-
America Movil Still A Buy After Painful Margin Squeeze
-
The Street Is Much Too Optimistic About Hospira
-
Heinz May Be A Buffett Stock, But This Isn't A Buffett Price
- Buy Cisco And Take Advantage Of A Change For The Better
-
Lundbeck Could Cheer Up Patient Investors
-
Deere: Mayan Apocalypse Never Materialized, But Mind The Valuation
-
After The Twists And Turns, Sanofi Still A Value
-
EnteroMedics May Get Approval, But Will It Get Sales?
-
A Stumble In Tonnage May Be An Opportunity At Old Dominion
- The FDA Throws Novo Nordisk Off Course
